CLOSE
SITE MAP
イノベーションが
生まれる「まち」。

2017/10/18

AFI Corporation's business

Takaharu Enjoji, CEO, AFI Corporation

AFI Corporation aims to make fluid electric filtering and sorting technology, an innovative separation technology called "FES" for short, a global standard. AFI, our company's name, is an abbreviation of Advanced Filtration Industries Technology. AFI's core technology, FES, is an innovative separation technology combining electric measuring technology and fluid control technology. FES makes it possible to separate target cells and impurities without prior labeling. We provide our products using FES to address problems faced by many industries.
FES is divided into two types: "continuous separation type" used to separate cells, such as iPS cells, and "concentration separation type" used to detect bacteria. Our first product launched in 2016 was ELESTA, a highly sensitive device in a simplified model to detect bacteria quickly using concentration separation type technology. The target market of ELESTA is the quality inspection market for foods and beverages. We are currently developing products under the ELESTA series, including products targeting the market of clinical research using circulating tumor cells (CTCs) and those targeting the market of cell separation for iPS and other cells, which are scheduled to be launched in 2018 and following years.

[Mentors' comments]
"If it is proven that bacteria can be removed entirely, there would be a huge market for the product as filters for intravenous administration of cells and other parenteral administration." Sham Nikam, Takeda Pharmaceuticals

"While the presentation was focused on the introduction of technological features, I think it would be more effective to show customer benefits and differences from the products of other companies." Elizabeth Steele, MassBIO

img03.jpg

[Speaker Profile]
Mr. Enjoji worked at SHIGEMATSU WORKS of an industrial respirator manufacturer as a chief engineer of R&D division for ten years. He founded FILTECHNO JAPAN in 2007 specialized to dielectrophoresis (DEP) technology, a sort of electrostatic phenomena, and developed flow-separation tools of microorganisms for university and food/beverage industry researchers. In 2013, He founded AFI Corporation and started to develop the rapid microorganisms detection equipment "ELESTA" based on DEP technologies. He assumed CEO in 2014. He holds a PhD in engineering from Tokyo Metropolitan University in 2012. His specialty is microbiology and DEP.
AFI Corporation website: http://afi.co.jp/

>> HVC KYOTO2017